The FDA Confronts a Market That Already Exists On July 23 and 24, 2026, an FDA advisory committee will begin examining whether seven peptide compounds should become eligible for pharmacy compounding
Weight loss injections include semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, and Mounjaro
Scientists identified a need for a more effective GLP-1 receptor agonist, sparking the initial studies
Glucagon remains below 0.3% even at 15 mg, ruling out the glucagon-driven liver and heart effects seen with retatrutide. GIPR: the identity receptor At the 2.5 mg starter dose, GIP receptor occupancy is already about 13%
They are used to regulate appetite and blood sugar levels
Seek immediate medical attention if severe side effects or allergic reactions occur